Cognet-X, Inc.: Managed
Care Executives Rank Wyeth Best for Pull-through Programs
FEASTERVILLE---(May 20, 2003)--- In the
first-quarter 2003, Wyeth ranked first with leading managed care pharmacy
directors for offering the best pull-through programs, Cognet-X, Inc. reported
today.
This marked the third consecutive time that
Wyeth placed first in the Pull-through Programs category, one of several
Corporate Assessment categories in Cognet-X's PAR-Rx (Promotional Assessment
Research) Report™. Points are accrued through Cognet~X's proprietary Scale
of Influence model. Cognet-X PAR~Rx panelists participate in Corporate
Assessment rankings twice each year.
Pull-through programs are pharmaceutical
company initiatives designed to increase the market share of specific products
while reducing pharmaceutical expenditures for managed care organizations.
In addition to Wyeth's first-place ranking,
another trend continued in the first quarter Pull-through Programs assessment.
Two other top-five companies in the Pull-through Programs category market
proton pump inhibitors. Wyeth markets Protonix. AstraZeneca manufactures
Nexium (and the now off-patent Prilosec); AstraZeneca ranked second, up from
third place in the 3Q 2002 ranking period. TAP Pharmaceuticals, Inc. retained
its fourth-place ranking; TAP promotes Prevacid.
Novartis placed third; it had been ranked
second in the previous assessment cycle. Sankyo Pharma, which was previously
not ranked in this category, finished fifth in the 1Q 2003 cycle.
Three other companies climbed into the top 10
rankings in the first-quarter assessment period. Joining the top 10 firms in
the Pull-through Programs category were: Hoffmann-La Roche, Inc. (eighth, up
from 17th); Novo Nordisk Pharmaceuticals (ninth, up from 12th); and Takeda
(tied for ninth, up from 16th).
Merck & Co., Inc. and Pharmacia Corp.
(pre-merger with Pfizer, Inc.) tied for sixth place in the 1Q 2003 period,
followed by Abbott Laboratories in seventh place. Aventis Pharma AG, which had
ranked sixth in the 3Q 2002 period, ranked 10th in the most recent
Pull-through Programs assessment.
About the PAR-Rx Report
Cognet-X’s PAR-Rx Report is a year-round service that
provides the pharmaceutical industry with real-time, Internet-based
competitive intelligence on pharmaceutical company promotion to influential
managed care pharmacy directors.
The Report offers Cognet-X clients the ability to
evaluate and analyze variable differences that are critically important to
their decision-making process. The Report collects comprehensive data that can
be segmented and analyzed to provide clients with “21st-Century
solutions to their 21st-Century challenges.”
About Cognet-X
Cognet-X offers the pharmaceutical industry market
research, consulting and software development that help companies build and
refine their relationships with numerous customer bases, including the managed
care community. Based in Bucks County, Pennsylvania, Cognet-X is privately
held and employee-owned.
For more information on the PAR-Rx Report or other
valuable Cognet-X products, please contact Robert E. Houghton (extension 101)
or James A. Barone (extension 102) at (215) 396-8300 or via e-mail at
robh@cognetx.com
or
jimb@cognetx.com.
